wonjinho1 Profile Banner
Won Jin Ho Profile
Won Jin Ho

@wonjinho1

Followers
364
Following
340
Media
13
Statuses
152

Medical Oncologist, Physician-Scientist, Focused on GI Immuno-Oncology and TME research @ConvergenceInst @hopkinskimmel

Baltimore, MD
Joined June 2018
Don't wanna be here? Send us removal request.
@wonjinho1
Won Jin Ho
10 days
RT @manorlaboratory: My lab’s 5-year NIH R01 grant, awarded to study gene therapy for hearing loss, was abruptly terminated. I want to shar….
0
2K
0
@wonjinho1
Won Jin Ho
17 days
0
0
1
@wonjinho1
Won Jin Ho
17 days
RT @Aiims1742: New cross species study examining #PancreaticCancer precursors in @jclinicalinvest from @NeehaZaidi @wonjinho1 @DrLizJaffee….
0
36
0
@wonjinho1
Won Jin Ho
3 months
RT @danielzabransky: 1/ Excited to share our study ( published today in @NatureComms led by @ChesterKao1, @SorenCha….
0
5
0
@wonjinho1
Won Jin Ho
3 months
RT @BlueFaeryLiver: Congratulations to @MarkYarchoan for winning the 2025 Blue Faery Award for Excellence in #LiverCancer #Research! #nonpr….
0
2
0
@wonjinho1
Won Jin Ho
7 months
High parameter spatial biology has grown into a standard approach in biological research. Really amazing to see the widespread recognition and take part in the adoption of this method!.
@BodenmillerLab
Bodenmiller lab
7 months
It's wonderful to see that spatial proteomics has been recognized as Nature Methods' Method of the Year 2024.
0
0
3
@wonjinho1
Won Jin Ho
7 months
RT @BodenmillerLab: It's wonderful to see that spatial proteomics has been recognized as Nature Methods' Method of the Year 2024. https://t….
0
3
0
@wonjinho1
Won Jin Ho
9 months
Just spectacular work by @DanielShuMD.
@MarkYarchoan
Mark Yarchoan
9 months
1/8 Excited to share our latest study in @NatImmunol led by @DanielShuMD on TLS in #HCC patients treated w/ neoadj ICB:.⏩ TLS linked to improved outcomes.⏩ Novel "involuted" TLS found in tumor regression zones.🔗
Tweet media one
0
0
4
@wonjinho1
Won Jin Ho
9 months
A seminar to look forward to.
@JohnsHopkinsBMB
Johns Hopkins BMB
9 months
Next week’s BMB seminar features a presentation by Daniel Zabransky, Assistant Professor, Oncology Department, Johns Hopkins University School of Medicine:.🗓️Wednesday October 23.🕚11 a.m. 📍W5030
Tweet media one
0
0
2
@wonjinho1
Won Jin Ho
9 months
Very interested in seeing how this observation will lead to new maneuvers in IO therapy moving forward-. More covered here:
0
1
4
@wonjinho1
Won Jin Ho
9 months
Really enjoyed leveraging latest workflow tricks. The ability to batch 30+ samples per run by live-cell barcoding for CyTOF enhanced the rigor of the analysis + @SorenCharmsaz and @NicoleElizGross employed CytoNorm (@SofieVanGassen) to further normalize the data across batches.
@MarkYarchoan
Mark Yarchoan
9 months
1/Excited to share our latest research led by @ChesterKao1 & @SorenCharmsaz , published in .@jclinicalinvest! .➡️We found that immune-related adverse events (irAEs) in patients receiving IO are linked to Th17 and Th2 signatures
1
4
12
@wonjinho1
Won Jin Ho
9 months
RT @MarkYarchoan: 1/Excited to share our latest research led by @ChesterKao1 & @SorenCharmsaz , published in .@jclinicalinvest! .➡️We found….
0
5
0
@wonjinho1
Won Jin Ho
9 months
RT @MarkYarchoan: In light of the negative #IMbrave050 study (no benefit w/ adj atezo+bev), a timely study by @mnakazawa7 supporting neoadj….
0
15
0
@wonjinho1
Won Jin Ho
10 months
RT @JCI_insight: Awakening the tumor immune microenvironment. Strategy from @NicoleElizGross, Zhehao Zhang et al. enhances antitumor effi….
0
2
0
@wonjinho1
Won Jin Ho
10 months
incredible work led by @DNSidiropoulos to peruse through the TLS forming in PDAC - a great show of making the most of multiple state-of-the-art tools to synthesize our understanding
Tweet media one
@Aiims1742
Anirban Maitra
10 months
New preprint from @ltkagohara @FertigLab @DrLizJaffee @wonjinho1 @AshleyKiemen @AshaniTW & colleagues @hopkinskimmel @ConvergenceInst .Spatial multi-omics reveal intratumoral humoral immunity niches associated with tertiary lymphoid structures in #PancreaticCancer immunotherapy
Tweet media one
Tweet media two
1
3
15
@wonjinho1
Won Jin Ho
10 months
many thanks to the whole team + dung le, katie bever, @DrLizJaffee.
0
0
1
@wonjinho1
Won Jin Ho
10 months
our ligand-receptor work using domino suggests vax + pde5i supports active il12 and cxcr3 signaling and inactive notch signaling.the effect on efficacy is modest but the study is a lesson on looking broadly at opportunities for overcoming tough immunosuppressive barriers in pdac.
1
0
1
@wonjinho1
Won Jin Ho
10 months
using a high-bar immunotherapy-resistant model of PDAC, we show that tadalafil added to msln-listeria and ICI combo improves resistance against pdac growth- we then reveal using cytof and scRNAseq to identify reduction of mhcii-/lo CD206hi macs and enrichment of ifn-pathways.
1
0
1
@wonjinho1
Won Jin Ho
10 months
finally out in full form - i'm excited to share our work showing the utility of adding a PDE-5 inhibitor onto vaccine (msln-listeria) to reprogram the myeloid cells in PDAC - led by the amazing @NicoleElizGross carter zhang, also jacob mitchell @FertigLab.
Tweet media one
1
3
13
@wonjinho1
Won Jin Ho
11 months
Very excited to share our recent work with amazing collaborators @EloiseGrasset and Andy Ewald showing key spatial relationships between metastasis-initiating cancer cells and macrophage subtypes!.
0
2
5